Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: NovoLog, NovoRapid
NovoLog is a rapid-acting insulin analog used to manage blood sugar levels in people with type 1 and type 2 diabetes. It is a recombinant human insulin analog produced by DNA technology. It works by mimicking the action of natural insulin, allowing glucose to enter cells for energy and helping to lower blood glucose levels.
For managing blood sugar levels in individuals with type 1 and type 2 diabetes.
Outcome:
Increased risk of heart failure
Mechanism:
Synergistic effect on fluid retention
Outcome:
Hyperglycemia
Mechanism:
Impaired glucose tolerance
Outcome:
Increased risk of hypoglycemia
Mechanism:
Enhanced insulin sensitivity
Most likely new formulation: Closed-loop automated insulin delivery systems incorporating NovoLog (2025, 75% confidence).
Based on current usage trends and clinical trial data, there is a 90% likelihood of continued FDA approval for NovoLog in the next 5 years.
Insulin, Rapid-Acting
Insulin Analog